[Why review answer criteria in solid tumors ?]
Rev Assoc Med Bras (1992)
.
2009 Jul-Aug;55(4):369-71.
doi: 10.1590/s0104-42302009000400005.
[Article in Portuguese]
Author
Marcelo Marotti
1
Affiliation
1
AstraZeneca Clinical Development, Alderley Park, England.
PMID:
19750296
DOI:
10.1590/s0104-42302009000400005
No abstract available
MeSH terms
Disease Progression*
Humans
Lymph Nodes / pathology
Neoplasms / pathology*
Practice Guidelines as Topic*